Whitehawk Therapeutics Inc

NASDAQ:WHWK

Biotechnology

Healthcare
$3.12 +1.42%

+$0.06 today

Market cap
$184.11M
Beta
0.77
P/E (TTM)
-2.6
EPS (TTM)
-$1.67
52W Low $1.57High $5.50

Volume 0.40M

Average 0.31M

Returns on capital

Whitehawk Therapeutics Inc management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-15.1%

avg -22.2%

ROIC

-83.9%

avg 247.7%

ROA

-13.7%

avg -49.8%

Analysis

ROA is currently the strongest return metric at -13.7% versus its period average of -49.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

David J. Lennon

President, Chief Executive Officer & DirectorUSD 1.07M55——

Scott Giacobello

Chief Financial Officer, Treasurer, Investor Relations & Corporate CommunicationsUSD 721.56K56——

Bryan Ball

Chief Technical Operations OfficerUSD 687.46K5691.63K0.19%

Neil Desai

Founder & DirectorUSD 40K6138.04K0.08%

David Dornan

Chief Scientific Officer—4885.89K0.17%

Margaret Han Dugan

Chief Medical Officer—69——

Stephen Rodin

Senior Vice President of Legal & General Counsel—50——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 15, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

14

$2.58M

Net Transaction Value

−$2.58M

Net selling

Most Active

Lennon David James

6 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Apr 16, 26

Giacobello Scott M.

Direct

Sell$584.8K
Apr 15, 26

Giacobello Scott M.

Direct

Sell$297.2K
Apr 14, 26

BALL BRYAN

Direct

Sell$336.6K
Apr 13, 26

BALL BRYAN

Direct

Sell$91.3K
Apr 10, 26

BALL BRYAN

Direct

Sell$22.6K
Apr 9, 26

BALL BRYAN

Direct

Sell$178.5K
Apr 9, 26

Lennon David James

Direct

Sell$49K
Apr 8, 26

Lennon David James

Direct

Sell$217.4K
Apr 7, 26

Lennon David James

Direct

Sell$322.7K
Apr 6, 26

Lennon David James

Direct

Sell$359.4K

1–10 of 14

Summary

Insiders reported 0 buys worth $0.00 and 14 sells worth $2.58M over the last 12 months. That adds up to net selling of $2.58M. Lennon David James was the most active insider with 6 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A4 analysts
RevenueN/AN/A-22.3%
+36.1% (5yr)6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Recent growth has been strongest in Revenue at -22.3% over three years. Forward estimates point to Revenue at +36.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Whitehawk Therapeutics Inc compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about WHWK's management, answered from reported figures.

Who manages WHWK?

Whitehawk Therapeutics Inc (WHWK) lists 7 active executives. The top listed executive is Bryan Ball, Chief Technical Operations Officer.

Are WHWK insiders buying or selling?

Recent insider activity shows net buying of $22.06M.